ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7804
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,439.52
1.05%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Syneron Medical Ltd. - Ordinary Shares (ELOS)

  7. Syneron Medical Ltd. - Ordinary Shares (ELOS) Noticias

ELOS

Syneron Medical Ltd. - Ordinary Shares (ELOS)

Syneron Medical Ltd. - Ordinary Shares
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ELOS
FechaHoraFuenteTítuloSímboloCompañía
01/08/201708:49Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
27/07/201708:01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201709:57Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201707:51Edgar (US Regulatory)(25-NSE)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201706:46Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/07/201706:30PR Newswire (US)Syneron Candela Completes Previously Announced Transaction with Funds Advised by Apax Partners and Becomes a Private CompanyNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
07/07/201710:55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
15/06/201708:22PR Newswire (US)Syneron Candela Announces Shareholder Approval of Proposed Acquisition by Funds Advised by Apax PartnersNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
23/05/201707:37Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/05/201716:00PR Newswire (US)Syneron Medical Reports First Quarter 2017 Revenue of $66.9 MillionNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
10/05/201705:13Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
10/05/201705:00PR Newswire (US)Syneron Candela Announces End of Go-Shop PeriodNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
03/04/201711:31Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
27/03/201703:00PR Newswire (US)Syneron Candela Announces CE Mark for CO2RE® IntimaNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
23/03/201715:10PR Newswire (US)Syneron Medical Ltd. Announces Availability of its Annual Report on Form 20-F through its WebsiteNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
23/03/201714:43Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
20/03/201715:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
01/03/201714:05PR Newswire (US)Syneron Candela Announces New Technology and Indications at the 2017 American Academy of Dermatology (AAD) Annual MeetingNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
15/02/201706:00PR Newswire (US)Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 MillionNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
13/02/201708:00PR Newswire (US)Syneron Medical to Participate in Leerink Partners 6th Annual Global Healthcare ConferenceNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
07/02/201708:00GlobeNewswire Inc.Sientra Appoints Aesthetic Industry Leader Philippe A. Schaison to Board of DirectorsNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
31/01/201715:05PR Newswire (US)Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources OfficerNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
30/01/201708:00PR Newswire (US)Syneron Medical to Report Fourth Quarter and Full Year 2016 Financial Results on February 15, 2017NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
11/11/201615:00PR Newswire (US)Syneron Medical to Participate in the Canaccord Genuity Medical Technologies and Diagnostics ForumNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
09/11/201606:00PR Newswire (US)Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 MillionNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
08/11/201608:00PR Newswire (US)Syneron Candela Announces FDA Clearance Of Profound™ SubQ To Improve The Appearance Of Cellulite, As Supported By Long Term...NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/10/201614:09Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
17/10/201606:00PR Newswire (US)Syneron Medical Strengthens Senior Management and Announces Preliminary Third Quarter 2016 RevenueNASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
08/09/201615:01Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
04/08/201606:00PR Newswire (US)Syneron Medical Reports Second Quarter 2016 Revenue of $75.0 Million and Non-GAAP EPS of $0.09NASDAQ:ELOSSyneron Medical Ltd. - Ordinary Shares
 Showing the most relevant articles for your search:NASDAQ:ELOS

Su Consulta Reciente

CCOM
US30
US 30
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NASDAQ
MSFT
Microsoft
USI
USTECH100
US Tech 100
NYSE
CVX
Chevron
NYSE
VZ
Verizon Communications
NYSE
KO
Coca Cola
NASDAQ
NVDA
NVIDIA
CCOM
OILBRENT
Brent Oil
NYSE
XOM
Exxon Mobil
NYSE
BAC
Bank of America
NYSE
DIS
Walt Disney
NYSE
NKE
Nike
FX
EURMXN
Euro vs MXN
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados